In the BioHarmony Drug Report Database

"Preview" Icon

Velaglucerase alfa

Vpriv (velaglucerase alfa) is an enzyme pharmaceutical. Velaglucerase alfa was first approved as Vpriv on 2010-02-26. It is used to treat gaucher disease in the USA. It has been approved in Europe to treat gaucher disease.

 

Trade Name

 

Vpriv
 

Common Name

 

velaglucerase alfa
 

ChEMBL ID

 

CHEMBL1201865
 

Indication

 

gaucher disease
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Velaglucerase alfa structure rendering